(1) Explanation of the purposes, description of the research, along with subjects’ expected participation |
|
-
1.
When I signed the consent form for my current HIV/AIDS treatment, I knew that I was agreeing to participate in a clinical trial.
-
2.
I have been informed how long my participation in this clinical trial will last.
-
3.
In my clinical trial, one of the researchers’ major purposes is to compare the effects (good and bad) of two or more different ways of treating patients with HIV/AIDS, in order to see which one is better.
-
4.
In my clinical trial, one of the researchers’ purposes is to test the safety of a new drug or new combination of drugs.
-
5.
In my clinical trial, one of the researchers’ purposes is to find out what effects (good or bad) a new treatment has on me.
-
6.
The treatment being researched in my clinical trial has been proven to be the best treatment.
-
7.
After I agreed to participate in my clinical trial, my treatment was chosen randomly (by chance) from two or more possibilities.
-
8.
In my clinical trial, I have a chance of getting a placebo in combination with treatment. A placebo is a pill that does not contain any medicine or drug.
-
9.
In my clinical trial, both my provider and I know which treatment I am receiving.
-
10.
The consent form I signed tells me what will happen when I participate in my clinical trial.
|
(2) description of any reasonably foreseeable risks or discomforts to subjects |
|
-
11.
If the treatment to which I have been assigned in my clinical trial gives me side effects, the provider can change it to another treatment.
-
12.
Compared with standard treatments, my clinical trial does not carry any additional risks or discomforts.
-
13.
I was given a list of possible side effects relating to the drugs studied in my clinical trial.
|
(3) description of any benefits to subjects |
|
-
14.
The main reason AIDS Clinical Trials are done is to improve the treatment of future HIV-positive or AIDS patients.
-
15.
By participating in this clinical trial, I am helping the researchers learn information that may benefit future HIV/AIDS patients.
|
(4) disclosure of appropriate alternative procedures or courses of treatment |
|
|
(5) information related to the confidentiality of data |
|
-
17.
Because I am participating in a clinical trial, it is possible that the study sponsor, government agencies, or others who are not directly involved in my care could review my medical records.
|
(6) for research involving more than minimal risk, an explanation of any compensation with respect to injury |
|
|
(7) explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights |
|
|
(8) a statement that participation is voluntary |
|
-
20.
I will have to remain in the clinical trial even if I decide someday that I want to withdraw.
-
21.
If I had not wanted to participate in this clinical trial, I could have declined to sign the consent form.
|